Results 51 to 60 of about 19,560 (233)
Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study [PDF]
, 2016 Purpose: The purpose of this study is to make a prospective evaluation of the effect of timolol 0.1% eye gel on short-term intraocular pressure (IOP) after an intravitreal injection (IVI) of ranibizumab. Participants and methods: One hundred and fifty
Allegrini, D. +3 more
core +3 more sources
Multi‐site performance of the telemedicine retinopathy of prematurity severity score (tROP‐SS)
Acta Ophthalmologica, EarlyView.Abstract Objective This study aims to evaluate the performance of the telemedicine retinopathy of prematurity severity score (tROP‐SS) across all 14 NICUs in the TELEROP cohort against the modified ROP activity score (mROP‐ActS). Design Retrospective cohort study. Subjects The study included 2037 neonates who underwent ROP screening in 14 NICUs via the
Sarthak V. Shah +6 more
wiley +1 more source
Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease
American Journal of Ophthalmology Case Reports, 2018 Purpose: To report a case of rapid “epiretinal membrane” (“ERM”) development following intravitreal bevacizumab for juvenile Coats' disease. Observations: A 7-year old boy was followed for four years with asymptomatic stage 2 Coats' disease in his left ...
Andrew W. Kam +3 more
doaj +1 more source
Medicina, 2021 The efficacy of combined intravitreal bevacizumab injection with systemic chemotherapy, palliative radiotherapy, and hormonal therapy to treat choroidal and orbital metastases is not known.
I-Hung Lin, Bo-I Kuo, Fang-Yu Liu
doaj +1 more source
Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections [PDF]
, 2012 PURPOSE: The aim of the this study was to determine the effect of intravitreal antivascular endothelial growth factor injections on intraocular pressure (IOP) and identify possible risk factors for the development of increased IOP. MATERIALS AND METHODS:
Lemos, V +6 more
core +2 more sources
The impact of systemic long‐term medications for the development of age‐related macular degeneration
Acta Ophthalmologica, EarlyView.Abstract Purpose Age‐related macular degeneration (AMD) is a leading cause of central vision loss in the elderly; however, the systemic factors that modulate its incidence and progression remain unclear. We sought to determine whether long‐term use of systemic medications, including diabetes and antithrombotic medications, corticosteroids and ...
Hanna Heloterä +3 more
wiley +1 more source
Indian Journal of Ophthalmology, 2020 We report the successful use of intravitreal bevacizumab in the iatrogenic choroidal neovascular membrane (CNVM) following vitreoretinal surgery. A 69-year-old male underwent vitrectomy surgery with silicone oil (SO) tamponade for rhegmatogenous retinal ...
Ramya Appanraj +4 more
doaj +1 more source
Acta Ophthalmologica, EarlyView.Abstract Purpose To assess the impact of biosimilar ranibizumab and on‐patent faricimab market entry on pricing and utilization trends and describe national variation in off‐label bevacizumab use in Europe. Methods Interrupted time series analysis of quarterly sales data (Q1 2018–Q2 2024) in 11 European countries evaluated ranibizumab utilization and ...
Elif Car +3 more
wiley +1 more source
Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
Case Reports in Nephrology, 2019 Introduction. Antiangiogenic agents that inhibit vascular endothelial growth factor have emerged as important tools in cancer therapy and ocular diseases. Their systemic use can induce renal limited microangiopathy.
F. Touzani, C. Geers, A. Pozdzik
doaj +1 more source
Ranibizumab For Diabetic Macular Edema Refractory To Multiple Prior Treatments [PDF]
, 2016 Purpose: Diabetic macular edema can be refractory to multiple treatment modalities. Although there have been anecdotal reports of ranibizumab showing efficacy when other modalities provided limited benefit, little has been published on treatment for ...
Ciulla, Lauren +4 more
core +2 more sources